Voxelotor for Patients with Sickle Cell Disease
Lidia’s
101 West 22nd Street
Kansas City, MO 64108
Thursday, February 15, 2024 at 6:00pm CT - 8:00pm CT
This event has ended.
Info
Credits Offered
This event offers
1.2 CNE credits
to attendees
(0.8 pharmacology)
.
Accreditation Info:
Greater Kansas City Chapter of the American Society of Pain Management Nursing is approved as a provider of continuing education by the Kansas State Board of Nursing. Provider number #LT0279-0412GKCC-542.
Attachments
Additional Information
DONNA MCCURRY, NP is an Advanced Practice Registered Nurse practitioner at the University Health. She will present "Voxelotor for Patients with Sickle Cell Disease" on February 15 at 6PM.
Objectives for this presentation:
- Discuss the role of hemoglobin S polymerization as a root cause of RBC sickling
- Explore how treatment with Voxelotor can intervene in the SCD Cascade
- Review efficacy and safety data from the Phase 3 Hope and Phase 2 Hope Kids 1 trials
- Discuss hypothetical patient cases who may be appropriate for Voxelotor
Dinner at Lidia's is included. This event is free thanks to our friends at Pfizer.
To attend please RSVP as space is limited!